Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.64), $0.08 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.